Advertisement

Overview of Sleep and Circadian Rhythm Disorders in Parkinson Disease

Published:October 17, 2019DOI:https://doi.org/10.1016/j.cger.2019.09.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Geriatric Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Chaudhuri K.R.
        • Martinez-Martin P.
        • Schapira A.H.
        • et al.
        International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
        Mov Disord. 2006; 21: 916-923
        • Hurt C.S.
        • Rixon L.
        • Chaudhuri K.R.
        • et al.
        Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's.
        Parkinsonism Relat Disord. 2019; 64: 220-225
        • Karlsen K.H.
        • Larsen J.P.
        • Tandberg E.
        • et al.
        Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 1999; 66: 431-435
        • American Academy of Sleep Medicine
        The international classification of sleep disorders: diagnostic and coding manual.
        3rd edition. American Academy of Sleep Medicine, Darien (IL)2014
        • Zhu K.
        • van Hilten J.J.
        • Marinus J.
        The course of insomnia in Parkinson's disease.
        Parkinsonism Relat Disord. 2016; 33: 51-57
        • Tholfsen L.K.
        • Larsen J.P.
        • Schulz J.
        • et al.
        Changes in insomnia subtypes in early Parkinson disease.
        Neurology. 2017; 88: 352-358
        • Loddo G.
        • Calandra-Buonaura G.
        • Sambati L.
        • et al.
        The treatment of sleep disorders in Parkinson's disease: from research to clinical practice.
        Front Neurol. 2017; 8: 42
        • Diederich N.J.
        • Vaillant M.
        • Mancuso G.
        • et al.
        Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients.
        Sleep Med. 2005; 6: 313-318
        • Louter M.
        • van Sloun R.J.
        • Pevernagie D.A.
        • et al.
        Subjectively impaired bed mobility in Parkinson disease affects sleep efficiency.
        Sleep Med. 2013; 14: 668-674
        • Gomez-Esteban J.C.
        • Zarranz J.J.
        • Lezcano E.
        • et al.
        Sleep complaints and their relation with drug treatment in patients suffering from Parkinson's disease.
        Mov Disord. 2006; 21: 983-988
        • Schutte-Rodin S.
        • Broch L.
        • Buysse D.
        • et al.
        Clinical guideline for the evaluation and management of chronic insomnia in adults.
        J Clin Sleep Med. 2008; 4: 487-504
        • Hogl B.
        • Arnulf I.
        • Comella C.
        • et al.
        Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.
        Mov Disord. 2010; 25: 2704-2716
        • Chung S.
        • Bohnen N.I.
        • Albin R.L.
        • et al.
        Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities.
        J Clin Sleep Med. 2013; 9: 1131-1137
        • Shafazand S.
        • Wallace D.M.
        • Arheart K.L.
        • et al.
        Insomnia, sleep quality, and quality of life in mild to moderate Parkinson's disease.
        Ann Am Thorac Soc. 2017; 14: 412-419
        • Wang H.T.
        • Wang L.
        • He Y.
        • et al.
        Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: a meta-analysis of randomized placebo-controlled trials.
        J Neurol Sci. 2018; 393: 31-38
        • Pierantozzi M.
        • Placidi F.
        • Liguori C.
        • et al.
        Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study.
        Sleep Med. 2016; 21: 140-144
        • De Fabregues O.
        • Ferre A.
        • Romero O.
        • et al.
        Sleep quality and levodopa intestinal gel infusion in Parkinson's disease: a pilot study.
        Parkinsons Dis. 2018; 2018: 8691495
        • Seppi K.
        • Ray Chaudhuri K.
        • Coelho M.
        • et al.
        Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.
        Mov Disord. 2019; 34: 180-198
        • Martino J.K.
        • Freelance C.B.
        • Willis G.L.
        The effect of light exposure on insomnia and nocturnal movement in Parkinson's disease: an open label, retrospective, longitudinal study.
        Sleep Med. 2018; 44: 24-31
        • O'Suilleabhain P.E.
        • Dewey Jr., R.B.
        Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease.
        Arch Neurol. 2002; 59: 986-989
        • Suzuki K.
        • Okuma Y.
        • Uchiyama T.
        • et al.
        Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
        J Neurol Neurosurg Psychiatry. 2017; 88: 953-959
        • Amara A.W.
        • Chahine L.M.
        • Caspell-Garcia C.
        • et al.
        Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.
        J Neurol Neurosurg Psychiatry. 2017; 88: 653-662
        • Liguori C.
        • Mercuri N.B.
        • Albanese M.
        • et al.
        Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
        J Neurol. 2019; 266: 636-641
        • Braak H.
        • Del Tredici K.
        • Rub U.
        • et al.
        Staging of brain pathology related to sporadic Parkinson's disease.
        Neurobiol Aging. 2003; 24: 197-211
        • Yeung E.Y.H.
        • Cavanna A.E.
        Sleep attacks in patients with Parkinson's disease on dopaminergic medications: a systematic review.
        Movement Disord Clin Pract. 2014; 1: 307-316
        • Johns M.W.
        Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard.
        J Sleep Res. 2000; 9: 5-11
        • Junho B.T.
        • Kummer A.
        • Cardoso F.
        • et al.
        Clinical predictors of excessive daytime sleepiness in patients with Parkinson's disease.
        J Clin Neurol (Seoul, Korea). 2018; 14: 530-536
        • Xiang Y.Q.
        • Xu Q.
        • Sun Q.Y.
        • et al.
        Clinical features and correlates of excessive daytime sleepiness in Parkinson's disease.
        Front Neurol. 2019; 10: 121
        • Neikrug A.B.
        • Liu L.
        • Avanzino J.A.
        • et al.
        Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.
        Sleep. 2014; 37: 177-185
        • Kaminska M.
        • Mery V.P.
        • Lafontaine A.L.
        • et al.
        Change in cognition and other non-motor symptoms with obstructive sleep apnea treatment in Parkinson disease.
        J Clin Sleep Med. 2018; 14: 819-828
        • Videnovic A.
        • Klerman E.B.
        • Wang W.
        • et al.
        Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: a randomized clinical trial.
        JAMA Neurol. 2017; 74: 411-418
        • Buchele F.
        • Hackius M.
        • Schreglmann S.R.
        • et al.
        Sodium oxybate for excessive daytime sleepiness and sleep disturbance in Parkinson disease: a randomized clinical trial.
        JAMA Neurol. 2018; 75: 114-118
        • Valko P.O.
        • Hauser S.
        • Sommerauer M.
        • et al.
        Observations on sleep-disordered breathing in idiopathic Parkinson's disease.
        PLoS One. 2014; 9: e100828
        • Beland S.G.
        • Postuma R.B.
        • Latreille V.
        • et al.
        Observational study of the relation between Parkinson's disease and sleep apnea.
        J Parkinsons Dis. 2015; 5: 805-811
        • Kaminska M.
        • Lafontaine A.L.
        • Kimoff R.J.
        The interaction between obstructive sleep apnea and Parkinson's disease: possible mechanisms and Implications for cognitive function.
        Parkinsons Dis. 2015; 2015: 849472
        • Hirotsu C.
        • Haba-Rubio J.
        • Andries D.
        • et al.
        Effect of three hypopnea scoring criteria on OSA prevalence and associated comorbidities in the general population.
        J Clin Sleep Med. 2019; 15: 183-194
        • Levy P.
        • Kohler M.
        • McNicholas W.T.
        • et al.
        Obstructive sleep apnoea syndrome.
        Nat Rev Dis Primers. 2015; 1: 15015
        • Trotti L.M.
        • Bliwise D.L.
        No increased risk of obstructive sleep apnea in Parkinson's disease.
        Mov Disord. 2010; 25: 2246-2249
        • Bahia C.
        • Pereira J.S.
        • Lopes A.J.
        Laryngopharyngeal motor dysfunction and obstructive sleep apnea in Parkinson's disease.
        Sleep Breath. 2019; 23: 543-550
        • Gros P.
        • Mery V.P.
        • Lafontaine A.L.
        • et al.
        Obstructive sleep apnea in Parkinson's disease patients: effect of Sinemet CR taken at bedtime.
        Sleep Breath. 2016; 20: 205-212
        • Tsai C.C.
        • Wu M.N.
        • Liou L.M.
        • et al.
        Levodopa reverse stridor and prevent subsequent endotracheal intubation in Parkinson disease patients with bilateral vocal cord palsy: a case report.
        Medicine (Baltimore). 2016; 95: e5559
        • Kapur V.K.
        • Auckley D.H.
        • Chowdhuri S.
        • et al.
        Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American academy of sleep medicine clinical practice guideline.
        J Clin Sleep Med. 2017; 13: 479-504
        • Gros P.
        • Mery V.P.
        • Lafontaine A.L.
        • et al.
        Diagnosis of obstructive sleep apnea in Parkinson's disease patients: is unattended portable monitoring a suitable tool?.
        Parkinsons Dis. 2015; 2015: 258418
        • Mery V.P.
        • Gros P.
        • Lafontaine A.L.
        • et al.
        Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
        Neurology. 2017; 88: 1120-1128
        • Huang J.Y.
        • Zhang J.R.
        • Shen Y.
        • et al.
        Effect of rapid eye movement sleep behavior disorder on obstructive sleep apnea severity and cognition of Parkinson's disease patients.
        Chin Med J (Engl). 2018; 131: 899-906
        • Yang X.
        • Liu B.
        • Shen H.
        • et al.
        Prevalence of restless legs syndrome in Parkinson's disease: a systematic review and meta-analysis of observational studies.
        Sleep Med. 2018; 43: 40-46
        • Szatmari Jr., S.
        • Bereczki D.
        • Fornadi K.
        • et al.
        Association of restless legs syndrome with incident Parkinson's disease.
        Sleep. 2017; 40
        • Lee J.E.
        • Shin H.W.
        • Kim K.S.
        • et al.
        Factors contributing to the development of restless legs syndrome in patients with Parkinson disease.
        Mov Disord. 2009; 24: 579-582
        • Angelini M.
        • Negrotti A.
        • Marchesi E.
        • et al.
        A study of the prevalence of restless legs syndrome in previously untreated Parkinson's disease patients: absence of co-morbid association.
        J Neurol Sci. 2011; 310: 286-288
        • Moccia M.
        • Erro R.
        • Picillo M.
        • et al.
        A four-year longitudinal study on restless legs syndrome in Parkinson disease.
        Sleep. 2016; 39: 405-412
        • Fereshtehnejad S.M.
        • Shafieesabet M.
        • Shahidi G.A.
        • et al.
        Restless legs syndrome in patients with Parkinson's disease: a comparative study on prevalence, clinical characteristics, quality of life and nutritional status.
        Acta Neurol Scand. 2015; 131: 211-218
        • Ferini-Strambi L.
        • Carli G.
        • Casoni F.
        • et al.
        Restless legs syndrome and Parkinson disease: a causal relationship between the two disorders?.
        Front Neurol. 2018; 9: 551
        • Alonso-Navarro H.
        • Garcia-Martin E.
        • Agundez J.A.G.
        • et al.
        Association between restless legs syndrome and other movement disorders.
        Neurology. 2019; 92: 948-964
        • Videnovic A.
        Disturbances of sleep and alertness in Parkinson's disease.
        Curr Neurol Neurosci Rep. 2018; 18: 29
        • Garcia-Borreguero D.
        • Silber M.H.
        • Winkelman J.W.
        • et al.
        Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
        Sleep Med. 2016; 21: 1-11
        • Hogl B.
        • Stefani A.
        Restless legs syndrome and periodic leg movements in patients with movement disorders: specific considerations.
        Mov Disord. 2017; 32: 669-681
        • Ma J.F.
        • Wan Q.
        • Hu X.Y.
        • et al.
        Efficacy and safety of pramipexole in Chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
        Sleep Med. 2012; 13: 58-63
        • Oertel W.H.
        • Benes H.
        • Garcia-Borreguero D.
        • et al.
        Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study.
        Sleep Med. 2010; 11: 848-856
        • Walters A.S.
        • Ondo W.G.
        • Dreykluft T.
        • et al.
        Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
        Mov Disord. 2004; 19: 1414-1423
        • Walters A.S.
        • Ondo W.G.
        • Kushida C.A.
        • et al.
        Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
        Clin Neuropharmacol. 2009; 32: 311-320
        • Allen R.P.
        • Chen C.
        • Garcia-Borreguero D.
        • et al.
        Comparison of pregabalin with pramipexole for restless legs syndrome.
        N Engl J Med. 2014; 370: 621-631
        • Winkelman J.W.
        • Armstrong M.J.
        • Allen R.P.
        • et al.
        Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology.
        Neurology. 2016; 87: 2585-2593
        • Chahine L.M.
        • Ahmed A.
        • Sun Z.
        Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures.
        Parkinsonism Relat Disord. 2011; 17: 208-211
        • Klepitskaya O.
        • Liu Y.
        • Sharma S.
        • et al.
        Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.
        Neurology. 2018; 91: e1013-e1021
        • Bonuccelli U.
        • Del Dotto P.
        • Lucetti C.
        • et al.
        Diurnal motor variations to repeated doses of levodopa in Parkinson's disease.
        Clin Neuropharmacol. 2000; 23: 28-33
        • Niwa F.
        • Kuriyama N.
        • Nakagawa M.
        • et al.
        Circadian rhythm of rest activity and autonomic nervous system activity at different stages in Parkinson's disease.
        Auton Neurosci. 2011; 165: 195-200
        • Bolitho S.J.
        • Naismith S.L.
        • Rajaratnam S.M.
        • et al.
        Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.
        Sleep Med. 2014; 15: 342-347
        • Videnovic A.
        • Messinis L.
        Enlightened PD: a novel treatment for Parkinson disease?.
        Neurology. 2019; 92: 499-500
        • Willis G.L.
        • Turner E.J.
        Primary and secondary features of Parkinson's disease improve with strategic exposure to bright light: a case series study.
        Chronobiol Int. 2007; 24: 521-537
        • Fifel K.
        • Videnovic A.
        Chronotherapies for Parkinson's disease.
        Prog Neurobiol. 2019; 174: 16-27
        • Zhang J.
        • Xu C.Y.
        • Liu J.
        Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease.
        BMC Neurol. 2017; 17: 23
        • Mollenhauer B.
        • Trautmann E.
        • Sixel-Doring F.
        • et al.
        Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort.
        Neurology. 2013; 81: 1226-1234
        • Postuma R.B.
        • Iranzo A.
        • Hu M.
        • et al.
        Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.
        Brain. 2019; 142: 744-759
        • Postuma R.B.
        • Berg D.
        Advances in markers of prodromal Parkinson disease.
        Nat Rev Neurol. 2016; 12: 622-634
        • Claassen D.O.
        • Josephs K.A.
        • Ahlskog J.E.
        • et al.
        REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.
        Neurology. 2010; 75: 494-499
        • Boeve B.F.
        • Silber M.H.
        • Saper C.B.
        • et al.
        Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.
        Brain. 2007; 130: 2770-2788
        • Stiasny-Kolster K.
        • Mayer G.
        • Schafer S.
        • et al.
        The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument.
        Mov Disord. 2007; 22: 2386-2393
        • Li K.
        • Li S.H.
        • Su W.
        • et al.
        Diagnostic accuracy of REM sleep behaviour disorder screening questionnaire: a meta-analysis.
        Neurol Sci. 2017; 38: 1039-1046
        • Kim Y.
        • Kim Y.E.
        • Park E.O.
        • et al.
        REM sleep behavior disorder portends poor prognosis in Parkinson's disease: a systematic review.
        J Clin Neurosci. 2018; 47: 6-13
        • St Louis E.K.
        • Boeve B.F.
        REM sleep behavior disorder: diagnosis, clinical implications, and future directions.
        Mayo Clin Proc. 2017; 92: 1723-1736
        • Arnaldi D.
        • Antelmi E.
        • St Louis E.K.
        • et al.
        Idiopathic REM sleep behavior disorder and neurodegenerative risk: to tell or not to tell to the patient? How to minimize the risk?.
        Sleep Med Rev. 2017; 36: 82-95
        • Dauvilliers Y.
        • Schenck C.H.
        • Postuma R.B.
        • et al.
        REM sleep behaviour disorder.
        Nat Rev Dis Primers. 2018; 4: 19
        • Gagnon J.F.
        • Postuma R.B.
        • Montplaisir J.
        Update on the pharmacology of REM sleep behavior disorder.
        Neurology. 2006; 67: 742-747
        • Aurora R.N.
        • Zak R.S.
        • Maganti R.K.
        • et al.
        Best practice guide for the treatment of REM sleep behavior disorder (RBD).
        J Clin Sleep Med. 2010; 6: 85-95
        • McCarter S.J.
        • Boswell C.L.
        • St Louis E.K.
        • et al.
        Treatment outcomes in REM sleep behavior disorder.
        Sleep Med. 2013; 14: 237-242